MKI67 and neoplasm: In a HuH6 xenograft mouse model (80 mg/kg/day aprepitant for 24 days), reduction of tumor growth (reduced tumor volume and weight) was reported along with a lowered tumor-specific alpha-fetoprotein (a marker of HB) serum level and a decreased number of Ki-67 positive cells (Table 2) [6].